Showing results (1201-1210 of 1,228) with videos related to

Sort By:
Pageof 123
Nature Protocols|June 21, 2023
Optimizing the Cell Painting assay for image-based profilingBeth A Cimini, Srinivas Niranj Chandrasekaran, Maria Kost-Alimova, et al.
Research Square|May 20, 2021
Systems biological assessment of human immunity to BNT162b2 mRNA vaccinationPrabhu S Arunachalam, Madeleine K D Scott, Thomas Hagan, et al.
Nature Medicine|January 12, 2021
Modeling human adaptive immune responses with tonsil organoidsLisa E Wagar, Ameen Salahudeen, Christian M Constantz, et al.
The Journal of Experimental Medicine|October 12, 2011
Initial antibodies binding to HIV-1 gp41 in acutely infected subjects are polyreactive and highly mutatedHua-Xin Liao, Xi Chen, Supriya Munshaw, et al.
Plos One|June 23, 2021
The Fc-mediated effector functions of a potent SARS-CoV-2 neutralizing antibody, SC31, isolated from an early convalescent COVID-19 patient, are essential for the optimal therapeutic efficacy of the antibodyConrad E Z Chan, Shirley G K Seah, De Hoe Chye, et al.
Immunity|April 3, 2026
Multiplexed antigen panel analysis identifies B cell phenotype and receptor genetic contributions to antibody breadthOliver F Wirz, Prasanti Kotagiri, Emily Haraguchi, et al.
Nature|July 12, 2021
Systems vaccinology of the BNT162b2 mRNA vaccine in humansPrabhu S Arunachalam, Madeleine K D Scott, Thomas Hagan, et al.
Vaccines|January 21, 2023
Reinfection with SARS-CoV-2 and Waning Humoral Immunity: A Case ReportJason D Goldman, Kai Wang, Katharina Röltgen, et al.
Allergy|July 21, 2024
Elucidating allergic reaction mechanisms in response to SARS-CoV-2 mRNA vaccination in adultsMihir M Shah, Janice A Layhadi, Dennis E Hourcade, et al.
Science Translational Medicine|January 18, 2022
Early non-neutralizing, afucosylated antibody responses are associated with COVID-19 severitySaborni Chakraborty, Joseph C Gonzalez, Benjamin L Sievers, et al.
Pageof 123